Spero Therapeutics (SPRO) EPS (Basic) (2016 - 2026)
Spero Therapeutics' (SPRO) quarterly EPS (Basic) came in at -$0.13 in Q1 2026, up 48.52% YoY from -$0.09 in Q1 2025, and down 124.63% on a QoQ basis from $0.52 in Q4 2025.
Spero Therapeutics (SPRO) EPS (Basic) (2016 - 2026) Analysis & Trends
Spero Therapeutics (SPRO) has 11 years of EPS (Basic) data on file, last reported at -$0.13 in Q1 2026.
- Quarterly EPS (Basic) rose 48.52% year-over-year to -$0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.98 (up 42.55% YoY) and the FY2025 annual result came in at $0.09, up 102.61% from the prior year.
- EPS (Basic) fell to -$0.13 in Q1 2026, from $0.52 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.52 in Q4 2025 to a low of -$2.64 in Q4 2024.
- A 5-year average of -$0.71 and a median of -$0.33 in 2022 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 119.82% in 2025, down 480.46% in 2025.
- Tracing SPRO's EPS (Basic) over 5 years: stood at -$2.46 in 2022, then soared by 54.01% to -$1.13 in 2023, then plunged by 133.59% to -$2.64 in 2024, then jumped by 119.82% to $0.52 in 2025, then plunged by 124.63% to -$0.13 in 2026.
- The last three EPS (Basic) figures came in at -$0.13 (Q1 2026), $0.52 (Q4 2025), and -$0.49 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Spero Therapeutics | 70.14 Mn | 19.37 Mn | - | -0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.17 |
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | 0.52 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -1.92 |
| Mar 31, 2025 | -0.25 |
| Dec 31, 2024 | -2.64 |
| Sep 30, 2024 | -0.31 |
| Jun 30, 2024 | -0.33 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -1.13 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | -0.23 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -2.46 |
| Sep 30, 2022 | -0.33 |
| Jun 30, 2022 | -0.79 |
| Mar 31, 2022 | -1.05 |
| Dec 31, 2021 | -4.21 |
| Sep 30, 2021 | -1.73 |